Antitumor activities of novel glycyrrhetinic acid-modified curcumin-loaded cationic liposomes in vitro and in H22 tumor-bearing mice

References

• Abu-Lila A, Suzuki T, Doi Y, et al. (2009). Oxaliplatin targeting to angiogenic vessels by PEGylated cationic liposomes suppresses the angiogenesis in a dorsal air sac mouse model. J Control Rel 134:18–25.
   PubMed Web of Science ®Google Scholar
• Bar-Sela G, Epelbaum R, Schaffer M. (2010). Curcumin as an anti-cancer agent: review of the gap between basic and clinical applications. Curr Med Chem 17:190–7.
   PubMed Web of Science ®Google Scholar
• Basnet P, Skalko-Basnet N. (2011). Curcumin: an anti-inflammatory molecule from a curry spice on the path to cancer treatment. Molecules 16:4567–98.
   PubMed Web of Science ®Google Scholar
• Bender E. (2014). Developing world: global warning. Nature 509:S64–S5.
   PubMed Web of Science ®Google Scholar
• Chainani-Wu N. (2003). Safety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa). J Altern Complement Med 9:161–8.
   PubMed Web of Science ®Google Scholar
• Cheng AL, Hsu CH, Lin JK, Hsu MM. (2001). Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 21:2895–900.
   PubMed Web of Science ®Google Scholar
• Churchill M, Chadburn A, Bilinski RT, Bertagnolli MM. (2000). Inhibition of intestinal tumors by curcumin is associated with changes in the intestinal immune cell profile. J Surg Res 89:169–75.
   PubMed Web of Science ®Google Scholar
• Ferlay J, Soerjomataram I, Dikshit R, et al. (2015). Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–86.
   PubMed Web of Science ®Google Scholar
• Forner A, Llovet JM, Bruix J. (2012). Hepatocellular carcinoma. Lancet 379:1245–55.
   PubMed Web of Science ®Google Scholar
• Gayong S, Kim M-G, Park JY, Oh Y-K. (2013). Application of cationic liposomes for delivery of nucleic acids. Asian J Pharma Sci 8:72–80.
   Google Scholar
• Hanmin Li, Zhihua Ye, Jun Z. (2014). Clinical trial with traditional Chinese medicine intervention “tonifying the kidney to promote liver regeneration and repair by affecting stem cells and their microenvironment” for chronic hepatitis B-associated liver failure. Wjg 20:18458–65.
   PubMed Web of Science ®Google Scholar
• Hanmin L. (2015). Construction and application of tertiary prevention program for liver cancer based on “tonifying the kidney to promote liver regeneration”. Chin J Integr Trad Westen Med Liver Dis 25:369–72.
   Google Scholar
• Hanmin L, Xuesheng y, An-ping M, et al. (2006). Stability of anti-liver cancer efficacy by liposome-curcumin in water solution. Chin Trad Herbal Drugs 37:561–5.
   Google Scholar
• Hanmin L, Xuesheng Y, Anping M. (2005). The effect of liposome-curcumin on inhibitory Bel-7402 cell proliferation and induction apoptosis. Chin J Integr Trad Western Med Liver Dis 15:214–7.
   Google Scholar
• Hanmin L, Zhang L. (2017). Liver regeneration microenvironment of hepatocellular carcinoma for prevention and therapy. Oncotarget 8:1805–13.
   PubMedGoogle Scholar
• Hanmin L, Zhao BB, Xiang G. (2015). Tonifying kidney to modulate liver regeneration microenviroment to prevent and cure liver cancer. J Hubei Uni Chin Med 17:5–8.
   Google Scholar
• He ZY, Zheng X, Wu XH, et al. (2010). Development of glycyrrhetinic acid-modified stealth cationic liposomes for gene delivery. Int J Pharm 397:147–54.
   PubMed Web of Science ®Google Scholar
• Hui X, Shengsheng L, Jiang Y. t, et al. (2006). Preparation of Glycyrrhetinic Acid Glycine and Nuclear magnetic resonance spectroscopy. Chin J Anal Chem 35:687–90.
   Google Scholar
• Huiqiang D, Renhui S, Jianxin T. (2017). Curcumin suppresses the colon cancer proliferation by inhibiting Wnt/β-Catenin pathways via miR-130a. Front Pharmacol 8:1–9.
   PubMed Web of Science ®Google Scholar
• Jingde C, Jiang H, Wu Y, Li Y, Gao Y. (2015). A novel glycyrrhetinic acid-modified oxaliplatin liposome for liver-targeting and in vitro/vivo evaluation. Drug Des Devel Ther 9:2265–75.
   PubMed Web of Science ®Google Scholar
• Jurenka JS. (2009). Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research. Altem Med Rev 14:141–53.
   PubMed Web of Science ®Google Scholar
• Lao CD, Ruffin MTIV, Normolle D, et al. (2006). Dose escalation of a curcuminoid formulation. BMC Complement Altern Med 6:10–9.
   PubMedGoogle Scholar
• Li H-M. (2017). Chinese medicine regulates liver regeneration: Research progress and prospect. Wcjd 25:1338–44.
   Google Scholar
• Liao YT, Liu CH, Yu J, Wu KC. (2014). Liver cancer cells: targeting and prolonged-release drug carriers consisting of mesoporous silica nanoparticles and alginate microspheres. Int J Nanomed 9:2767–78.
   PubMed Web of Science ®Google Scholar
• Lin S, Hoffmann K, Schemmer P. (2012). Treatment of hepatocellular carcinoma: a systematic review. Liver Cancer 1:144–58.
   PubMed Web of Science ®Google Scholar
• Lin A, Liu Y, Huang Y, et al. (2008). Glycyrrhizin surface-modified chitosan nanoparticles for he patocyte-targeted delivery. Int J Pharm 359:247–53.
   PubMed Web of Science ®Google Scholar
• Li S, Tseng WC, Stolz DB, et al. (1999). Dynamic changes in the characteristics of cationic lipidic vectors after exposure to mouse serum: implications for intravenous lipofection. Gene Ther 6:585–94.
   PubMed Web of Science ®Google Scholar
• Liu Z, Chiu M, Wang J, et al. (2012). Enhancement of curcumin oral absorption and pharmacokinetics of curcuminoids and curcumin metabolites in mice. Cancer Chemother Pharmacol 69:679–89.
   PubMed Web of Science ®Google Scholar
• Li H-m, Ye Z-h. (2017). The microenvironment of liver regeneration in liver cancer. Chin J Integr Med 23:555–60.
   PubMed Web of Science ®Google Scholar
• Maheshwari RK, Singh AK, Gaddipati J, Srimal RC. (2006). Multiple biological activities of curcumin: a short review. Life Sci 78:2081–7.
   PubMed Web of Science ®Google Scholar
• Makiya N, Yoshinobu T., Mitsuruh (2005). Theoretical considerations involving the pharmacokinetics of plasmid DNA. Adv Drug Deli Rev 57:675–88.
   PubMed Web of Science ®Google Scholar
• Mao SJ, Hou SX, He R, et al. (2005). Uptake of albumin nanoparticle surface modified with glycyrrhizin by primary cultured rat hepatocytes. WJG 11:3075–9.
   PubMed Web of Science ®Google Scholar
• Mingrong C, Gao X, Wang Y, et al. (2013). Synthesis of glycyrrhetinic acid-modified chitosan 5-fluorouracil nanoparticles and its inhibition of liver cancer characteristics in vitro and in vivo. Mar Drugs 11:3517–36.
   PubMed Web of Science ®Google Scholar
• Mingxiang C, Meimei W, Hangmin L. (2017). Inhibition on proliferation of hepatoma HepG2 cell treated with curcumin combined with glycyrrhetinic acid. Drug Eval Res 40:42–7.
   Google Scholar
• O'Brian CA, Ward NE, Vogel VG. (1990). Inhibition of protein kinase C by the 12-O-tetradecanoylphorbol-13-acetate antagonist glycyrrhetic acid. Cancer Lett 49:9–12.
   PubMed Web of Science ®Google Scholar
• Ojea-Jiménez I, Tort O, Lorenzo J, Puntes VF. (2012). Engineered nonviral nanocarriers for intracellular gene delivery applications. Biomed Mater 7:054106.
   PubMed Web of Science ®Google Scholar
• Patrick H, Mudi M, Natasha K. (2013). Targeting caspases in cancer therapeutics. J Biol Chem 394:831–43.
   Web of Science ®Google Scholar
• Sayoko O, Tsuji H, Kiwada H. (1994). Uptake of liposomes surface modified with glycyrrhizin by primary cultured rat hepatocytes. Biol Pharm Bull 17:940–3.
   PubMed Web of Science ®Google Scholar
• Shaomei Y, Zhang B, Gong X, Wang T, liu Y, Zhang N. (2016). In vivo biodistribution, biocompatibility, and efficacy of sorafenib-loaded lipid-based nanosuspensions evaluated experimentally in cancer. Int J Nanomed 11:2329–43.
   PubMed Web of Science ®Google Scholar
• Sharma RA, Euden SA, Platton SL, et al. (2004). Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin Cancer Res 10:6847–54.
   PubMed Web of Science ®Google Scholar
• Sharma RA, McLelland HR, Hill KA, et al. (2001). Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer. Clin Cancer Res 7:1894–900.
   PubMed Web of Science ®Google Scholar
• Shi W-R, Liu Y, Wang X-T, et al. (2015). Antitumor efficacy and mechanism in hepatoma H22-bearing mice of Brucea javanica Oil. Evidence-Based Comp Alter Med 2015 2015:1.
   Google Scholar
• Teiten MH, Eifes S, Dicato M, Diederich M. (2010). Curcumin-the paradigm of a multi-target natural compound with applications in cancer prevention and treatment. Toxins (Basel) 2:128–62.
   PubMed Web of Science ®Google Scholar
• Wang L, Nie ZK, Zhou Q, et al. (2014). Antitumor efficacy in H22 tumor bearing mice and immunoregulatory activity on raw 264.7 macrophages of polysaccharides from talinum triangulare. Food Funct 5:2183–93.
   PubMed Web of Science ®Google Scholar
• Wilken R, Veena MS, Wang MB, Srivatsan ES. (2011). Curcumin: a review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma. Mol Cancer 10:12–31.
   PubMed Web of Science ®Google Scholar
• Wu R, Ru Q, Chen L, et al. (2014). Stereospecificity of ginsenoside Rg3 in the promotion of cellular immunity in hepatoma H22-bearing mice. J Food Sci 79:H1430–5.
   PubMed Web of Science ®Google Scholar
• Wysocki PJ. (2010). Targeted therapy of hepatocellular cancer. Expert Opin Investig Drugs 19:265–74.
   PubMed Web of Science ®Google Scholar
• Xiao Y, Liu Y, Yang S, et al. (2016). Sorafenib and gadolinium co-loaded liposomes for drug delivery and MRI-guided HCC treatment. Colloids Surf B Biointerfaces 141:83–92.
   PubMed Web of Science ®Google Scholar
• Xin S, Sisi C, Yu P, et al. (2014). Attenuation of early liver fibrosis by herbal compound “DiwuYanggan” through modulating the balance between epithelial-to-mesenchymal transition and mesenchymal-to-epithelial transition. BMC Comp Alter Med 14:418.
   PubMed Web of Science ®Google Scholar
• Yang F, Li J, Zhu J, et al. (2015). Hydroxysaffor yellow a inhibits angiogenesis of hepatocellular carcinoma via blocking ERK/MAPK and NF-kB signaling pathway in H22 tumor-bearing mice. Eur J Pharmacol 754:105–14.
   PubMed Web of Science ®Google Scholar
• Young-Sam K, Jin K, Keun Hyung L, et al. (2002). Induction of apoptosis and caspase-3 activation by chemopreventive [6]-paradol and structurally related compounds in KB cells. Cancer Lett 177:41–7.
   PubMed Web of Science ®Google Scholar
• Yuan X, Naguib S, Wu Z. (2011). Recent advances of siRNA delivery by nanoparticles. Expert Opin Drug Deliv 8:521–36.
   PubMed Web of Science ®Google Scholar
• Zhao BB, Li HM, Gao X, et al. (2015). The herbal compound “diwuyanggan” modulates liver regeneration by affecting the hepatic stem cell microenvironment in 2-acetylaminofluorene/partial hepatectomy rats. Evid Based Complement Alter Med 2015: (2015). 1.
   Web of Science ®Google Scholar
• Zhou S, Zhang S, Shen H, et al. (2017). Curcumin inhibits cancer progression through regulating expression of microRNAs. Tumour Biol 39:101042831769168.
   PubMedGoogle Scholar
• Zolota V, Gerokosta A, Melachrinou M, et al. (1999). Microvessel density, proliferating activity, p53 and bcl-2 expression in situ ductal carcinoma of the breast. Anticancer Res 19:3269–74.
   PubMed Web of Science ®Google Scholar